Ignite Creation Date:
2025-12-24 @ 1:59 PM
Ignite Modification Date:
2026-01-08 @ 6:41 PM
Study NCT ID:
NCT05405595
Status:
RECRUITING
Last Update Posted:
2025-06-04
First Post:
2022-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
Sponsor:
Adagene Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ADG126-P001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |